Longboard Pharmaceuticals Stock Price on November 26, 2024
LBPH Stock | USD 59.98 0.02 0.03% |
If you're considering investing in Longboard Stock, it is important to understand the factors that can impact its price. As of today, the current price of Longboard Pharmaceuticals stands at 59.98, as last reported on the 29th of November, with the highest price reaching 60.03 and the lowest price hitting 59.98 during the day. Longboard Pharmaceuticals is somewhat reliable given 3 months investment horizon. Longboard Pharmaceuticals has Sharpe Ratio of 0.15, which conveys that the firm had a 0.15% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.13% are justified by taking the suggested risk. Use Longboard Pharmaceuticals Risk Adjusted Performance of 0.1154, downside deviation of 3.93, and Mean Deviation of 3.25 to evaluate company specific risk that cannot be diversified away.
As of now, Longboard Pharmaceuticals' Stock Based Compensation is decreasing as compared to previous years. The Longboard Pharmaceuticals' current Issuance Of Capital Stock is estimated to increase to about 38.5 M, while Common Stock Shares Outstanding is projected to decrease to under 20.5 M. . The Longboard Pharmaceuticals' current Price Earnings To Growth Ratio is estimated to increase to 0.55, while Price Earnings Ratio is projected to decrease to (2.64). Longboard Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Longboard |
Sharpe Ratio = 0.1498
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | LBPH | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
7.57 actual daily | 67 67% of assets are less volatile |
Expected Return
1.13 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Longboard Pharmaceuticals is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Longboard Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 8.5076 | Book Value 7.051 | Enterprise Value 2.1 B | Enterprise Value Ebitda (12.30) | Shares Float 25 M |
Related Headline
Assembly Biosciences Headline on 26th of November 2024
Andhra Pradesh Police arrested retired senior police officer Vijay Paul on Tuesday in connection with the alleged custodial torture case of K Raghurama Krishna Raju during the erstwhile YSRCP regime.
Longboard Pharmaceuticals Valuation on November 26, 2024
It is possible to determine the worth of Longboard Pharmaceuticals on a given historical date. On November 26, 2024 Longboard was worth 59.92 at the beginning of the trading date compared to the closed value of 59.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Longboard Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Longboard Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Longboard Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Longboard Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
59.83 | 59.95 | 59.80 | 59.91 | 407,608 | |
11/26/2024 | 59.92 | 59.95 | 59.88 | 59.95 | 1,078,203 |
59.96 | 59.98 | 59.94 | 59.96 | 872,293 |
Backtest Longboard Pharmaceuticals | | | Longboard Pharmaceuticals History | | | Longboard Pharmaceuticals Valuation | Previous | Next |
Longboard Pharmaceuticals Trading Date Momentum on November 26, 2024
On November 27 2024 Longboard Pharmaceuticals was traded for 59.96 at the closing time. The top price for the day was 59.98 and the lowest listed price was 59.94 . The trading volume for the day was 872.3 K. The trading history from November 27, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 0.02% . The trading delta at closing time against the current closing price is 0.07% . |
Longboard Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Longboard Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Longboard Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Longboard financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Longboard Pharmaceuticals Stock history
Longboard Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Longboard is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Longboard Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Longboard Pharmaceuticals stock prices may prove useful in developing a viable investing in Longboard Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 22.7 M | 20.5 M | |
Net Loss | -39.6 M | -41.5 M |
Longboard Pharmaceuticals Quarterly Net Working Capital |
|
Longboard Pharmaceuticals Stock Technical Analysis
Longboard Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Longboard Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Longboard Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Longboard Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Longboard Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Longboard Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Longboard Pharmaceuticals stock market strength indicators, traders can identify Longboard Pharmaceuticals entry and exit signals to maximize returns
Longboard Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Longboard Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Longboard Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Longboard to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1154 | |||
Jensen Alpha | 0.8569 | |||
Total Risk Alpha | (0.1) | |||
Sortino Ratio | 0.2308 | |||
Treynor Ratio | 0.7102 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Longboard Stock analysis
When running Longboard Pharmaceuticals' price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |